These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 7389219)

  • 1. Effects of corticosteroids on natural killer cell activity in systemic lupus erythematosus.
    Oshimi K; Gonda N; Sumiya M; Kano S
    Clin Exp Immunol; 1980 Apr; 40(1):83-8. PubMed ID: 7389219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural killer cell activity in families of patients with systemic lupus erythematosus: demonstration of a killing defect in patients.
    Green MR; Kennell AS; Larche MJ; Seifert MH; Isenberg DA; Salaman MR
    Clin Exp Immunol; 2005 Jul; 141(1):165-73. PubMed ID: 15958083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective natural killer (NK) and killer (K) cell function in systemic lupus erythematosus.
    Ewan PW; Barrett HM; Pusey CD
    J Clin Lab Immunol; 1983 Feb; 10(2):71-6. PubMed ID: 6842577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of natural killing with antibody dependent cell mediated cytotoxicity in patients with systemic lupus erythematosus.
    Kozlowski SH; Hirsen DJ; Jackson EJ
    J Rheumatol; 1982; 9(1):59-62. PubMed ID: 7086780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural and antibody-dependent cellular cytotoxicity in children with systemic lupus erythematosus and juvenile dermatomyositis.
    Miller ML; Lantner R; Pachman LM
    J Rheumatol; 1983 Aug; 10(4):640-2. PubMed ID: 6620266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal natural killer cell activity in systemic lupus erythematosus: an intrinsic defect in the lytic event.
    Katz P; Zaytoun AM; Lee JH; Panush RS; Longley S
    J Immunol; 1982 Nov; 129(5):1966-71. PubMed ID: 7119439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal macrophages and NK cell cytotoxicity in human systemic lupus erythematosus and the role of interferon and serum factors.
    Zippel D; Lackovic V; Kocisková D; Rovenský J; Borecký L; Stelzner A
    Acta Virol; 1989 Sep; 33(5):447-53. PubMed ID: 2483602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired differentiation and cytotoxicity of natural killer cells in systemic lupus erythematosus.
    Park YW; Kee SJ; Cho YN; Lee EH; Lee HY; Kim EM; Shin MH; Park JJ; Kim TJ; Lee SS; Yoo DH; Kang HS
    Arthritis Rheum; 2009 Jun; 60(6):1753-63. PubMed ID: 19479851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of serum from patients with system lupus erythematosus on leukocyte cytotoxicity: modulation of NK activity and ADCC.
    Ytterberg SR; Huard TK; Schnitzer TJ
    J Rheumatol; 1983 Dec; 10(6):906-12. PubMed ID: 6663595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recalcitrant trichophytic granuloma associated with NK-cell deficiency in a SLE patient treated with corticosteroid.
    Akiba H; Motoki Y; Satoh M; Iwatsuki K; Kaneko F
    Eur J Dermatol; 2001; 11(1):58-62. PubMed ID: 11174142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased DAP12 expression in natural killer lymphocytes from patients with systemic lupus erythematosus is associated with increased transcript mutations.
    Toyabe S; Kaneko U; Uchiyama M
    J Autoimmun; 2004 Dec; 23(4):371-8. PubMed ID: 15571931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of vitamin A treatment on the immune reactivity of patients with systemic lupus erythematosus.
    Vien CV; González-Cabello R; Bodó I; Gergely P
    J Clin Lab Immunol; 1988 May; 26(1):33-5. PubMed ID: 3184159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A killing defect of natural killer cells as an underlying immunologic abnormality in childhood systemic lupus erythematosus.
    Yabuhara A; Yang FC; Nakazawa T; Iwasaki Y; Mori T; Koike K; Kawai H; Komiyama A
    J Rheumatol; 1996 Jan; 23(1):171-7. PubMed ID: 8838528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct suppression of natural killer activity in human peripheral blood leukocyte cultures by glucocorticoids and its modulation by interferon.
    Holbrook NJ; Cox WI; Horner HC
    Cancer Res; 1983 Sep; 43(9):4019-25. PubMed ID: 6871844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural cell mediated cytotoxicity in systemic lupus erythematosus: suppression by antilymphocyte antibody.
    Goto M; Tanimoto K; Horiuchi Y
    Arthritis Rheum; 1980 Nov; 23(11):1274-81. PubMed ID: 6969594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of prednisolone on the systemic release of mediators of cell-mediated cytotoxicity during human endotoxemia.
    de Kruif MD; Lemaire LC; Giebelen IA; Groot AP; Pater JM; van den Pangaart PS; Elliott PJ; van der Poll T
    Shock; 2008 Apr; 29(4):458-61. PubMed ID: 17909456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prednisolone suppresses NK cell cytotoxicity in vitro in women with a history of infertility and elevated NK cell cytotoxicity.
    Thum MY; Bhaskaran S; Abdalla HI; Ford B; Sumar N; Bansal A
    Am J Reprod Immunol; 2008 Mar; 59(3):259-65. PubMed ID: 18275519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of Astragalus membranaceus and Tripterygium hypoglancum on natural killer cell activity of peripheral blood mononuclear in systemic lupus erythematosus].
    Zhao XZ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1992 Nov; 12(11):669-71, 645. PubMed ID: 1301849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low dose subcutaneous interleukin-2 after autologous transplantation generates sustained in vivo natural killer cell activity.
    Miller JS; Tessmer-Tuck J; Pierson BA; Weisdorf D; McGlave P; Blazar BR; Katsanis E; Verfaillie C; Lebkowski J; Radford J; Burns LJ
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):34-44. PubMed ID: 9209739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for local and systemic activation of immune cells by peritumoral injections of interleukin 2 in patients with advanced squamous cell carcinoma of the head and neck.
    Whiteside TL; Letessier E; Hirabayashi H; Vitolo D; Bryant J; Barnes L; Snyderman C; Johnson JT; Myers E; Herberman RB
    Cancer Res; 1993 Dec; 53(23):5654-62. PubMed ID: 8242620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.